In tumors, Akt increases the expression of glucose transporters GLUT1 and GLUT4 and activates enzymes involved in glycolysis such as HK and PFK1/2 (phosphofructokinase 1/2), thereby enhancing the viability of tumor cells undergoing aerobic glycolysis [88]. The gene discussed is SLC2A1; the disease is neoplasm.